Gershon A A
Annu Rev Med. 1987;38:41-50. doi: 10.1146/annurev.me.38.020187.000353.
Live attenuated varicella vaccine will in all probability soon be licensed in the United States for immunization of healthy children and adults and certain immunocompromised children. This vaccine can be expected to protect susceptibles from varicella (or to modify it) in those subsequently exposed to the wild virus. The vaccine is safe, immunogenic, and is not associated with an increase in the incidence of zoster.
减毒活水痘疫苗很有可能很快在美国获得许可，用于健康儿童、成人以及某些免疫功能低下儿童的免疫接种。这种疫苗有望保护易感人群在后续接触野生病毒时不患水痘（或减轻症状）。该疫苗安全、具有免疫原性，且与带状疱疹发病率的增加无关。
